Selective CellCept therapy in high-risk renal transplant recipients.
Isenberg, A
Selective CellCept therapy in high-risk renal transplant recipients. [electronic resource] - Transplantation proceedings Jun 1998 - 1188-9 p. digital
Publication Type: Journal Article
0041-1345
10.1016/s0041-1345(98)00202-4 doi
Adult
Azathioprine--therapeutic use
Cyclosporine--therapeutic use
Diabetes Mellitus, Type 1
Diabetic Nephropathies--surgery
Drug Therapy, Combination
Graft Rejection--prevention & control
Graft Survival
Humans
Immunosuppressive Agents--therapeutic use
Kidney Transplantation--immunology
Mycophenolic Acid--analogs & derivatives
Postoperative Complications--epidemiology
Prednisone--therapeutic use
Reoperation
Retrospective Studies
Survival Rate
Selective CellCept therapy in high-risk renal transplant recipients. [electronic resource] - Transplantation proceedings Jun 1998 - 1188-9 p. digital
Publication Type: Journal Article
0041-1345
10.1016/s0041-1345(98)00202-4 doi
Adult
Azathioprine--therapeutic use
Cyclosporine--therapeutic use
Diabetes Mellitus, Type 1
Diabetic Nephropathies--surgery
Drug Therapy, Combination
Graft Rejection--prevention & control
Graft Survival
Humans
Immunosuppressive Agents--therapeutic use
Kidney Transplantation--immunology
Mycophenolic Acid--analogs & derivatives
Postoperative Complications--epidemiology
Prednisone--therapeutic use
Reoperation
Retrospective Studies
Survival Rate